Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Meridian Bioscience Inc (VIVO) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Meridian Bioscience Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 794172.
Total stock buying since 2014: $1,974,115.
Total stock sales since 2014: $12,319,455.
Total stock option exercises since 2014: $5,543,109.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 0 | $0 | 8,500 | $173,230 |
| 2022 | 4,028 | $100,168 | 159,603 | $4,710,659 | 167,103 | $2,078,905 |
| 2021 | 0 | $0 | 215,132 | $5,970,199 | 134,682 | $1,699,507 |
| 2020 | 56,550 | $422,130 | 0 | $0 | 1,500 | $29,565 |
| 2019 | 62,000 | $601,336 | 0 | $0 | 0 | $0 |
| 2018 | 4,148 | $62,277 | 35,101 | $681,225 | 5,000 | $65,500 |
| 2017 | 15,154 | $199,015 | 0 | $0 | 0 | $0 |
| 2016 | 19,755 | $346,469 | 4,926 | $83,756 | 31,464 | $530,300 |
| 2015 | 3,109 | $57,718 | 14,351 | $283,034 | 52,464 | $698,562 |
| 2014 | 11,000 | $185,002 | 35,671 | $590,582 | 36,750 | $267,540 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-01 | 0 | $0 | 0 | $0 | 8,500 | $173,230 |
| 2022-06 | 0 | $0 | 139,603 | $4,198,739 | 139,603 | $1,650,355 |
| 2022-02 | 4,028 | $100,168 | 20,000 | $511,920 | 20,000 | $289,500 |
| 2022-01 | 0 | $0 | 0 | $0 | 7,500 | $139,050 |
| 2021-03 | 0 | $0 | 40,000 | $1,000,000 | 0 | $0 |
| 2021-02 | 0 | $0 | 175,132 | $4,970,199 | 134,682 | $1,699,507 |
| 2020-11 | 5,000 | $88,265 | 0 | $0 | 0 | $0 |
| 2020-06 | 0 | $0 | 0 | $0 | 1,500 | $29,565 |
| 2020-03 | 33,550 | $196,817 | 0 | $0 | 0 | $0 |
| 2020-02 | 18,000 | $137,048 | 0 | $0 | 0 | $0 |
| 2019-11 | 30,000 | $235,210 | 0 | $0 | 0 | $0 |
| 2019-05 | 32,000 | $366,126 | 0 | $0 | 0 | $0 |
| 2018-11 | 31 | $571 | 35,101 | $681,225 | 4,000 | $52,700 |
| 2018-10 | 0 | $0 | 0 | $0 | 1,000 | $12,800 |
| 2018-08 | 2,038 | $31,816 | 0 | $0 | 0 | $0 |
| 2018-05 | 40 | $555 | 0 | $0 | 0 | $0 |
| 2018-02 | 2,039 | $29,335 | 0 | $0 | 0 | $0 |
| 2017-11 | 38 | $553 | 0 | $0 | 0 | $0 |
| 2017-08 | 7,039 | $96,240 | 0 | $0 | 0 | $0 |
| 2017-05 | 36 | $536 | 0 | $0 | 0 | $0 |
| 2017-02 | 4,041 | $50,886 | 0 | $0 | 0 | $0 |
| 2017-01 | 4,000 | $50,800 | 0 | $0 | 0 | $0 |
| 2016-11 | 10,958 | $177,178 | 4,926 | $83,756 | 15,750 | $260,725 |
| 2016-08 | 1,032 | $20,189 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-06 | Anderson James M. (Director) | Option Ex | 8,500 | 20.38 | 173,230 |
| 2022-06-27 | Kenny John P. (Chief Executive Officer) | Sale | 61,437 | 30.39 | 1,866,763 |
| 2022-06-27 | Kenny John P. (Chief Executive Officer) | Option Ex | 61,437 | 10.10 | 620,513 |
| 2022-06-24 | Kenny John P. (Chief Executive Officer) | Sale | 13,559 | 30.00 | 406,837 |
| 2022-06-24 | Kenny John P. (Chief Executive Officer) | Option Ex | 13,559 | 10.10 | 136,945 |
| 2022-06-23 | Kenny John P. (Chief Executive Officer) | Sale | 19,956 | 29.98 | 598,201 |
| 2022-06-23 | Kenny John P. (Chief Executive Officer) | Option Ex | 19,956 | 12.30 | 245,458 |
| 2022-06-22 | Kenny John P. (Chief Executive Officer) | Sale | 44,651 | 29.72 | 1,326,938 |
| 2022-06-22 | Kenny John P. (Chief Executive Officer) | Option Ex | 44,651 | 14.50 | 647,439 |
| 2022-02-25 | Kitzmiller Andrew S. (EVP & CFO) | Buy | 4,028 | 24.87 | 100,168 |
| 2022-02-15 | Weltzien Lourdes (EVP, Life Science) | Sale | 20,000 | 25.60 | 511,920 |
| 2022-02-15 | Weltzien Lourdes (EVP, Life Science) | Option Ex | 20,000 | 14.47 | 289,500 |
| 2022-01-12 | Phillips David (Director) | Option Ex | 7,500 | 18.54 | 139,050 |
| 2021-03-17 | Kenny John P. (Chief Executive Officer) | Sale | 30,000 | 25.00 | 750,000 |
| 2021-03-10 | Kenny John P. (Chief Executive Officer) | Sale | 10,000 | 25.00 | 250,000 |
| 2021-02-16 | Kenny John P. (Chief Executive Officer) | Sale | 2,359 | 30.35 | 71,605 |
| 2021-02-16 | Kenny John P. (Chief Executive Officer) | Option Ex | 2,082 | 10.10 | 21,028 |
| 2021-02-12 | Kenny John P. (Chief Executive Officer) | Sale | 26,181 | 30.14 | 789,095 |
| 2021-02-12 | Kenny John P. (Chief Executive Officer) | Option Ex | 23,097 | 10.10 | 233,279 |
| 2021-02-11 | Kenny John P. (Chief Executive Officer) | Sale | 1,320 | 30.00 | 39,601 |
| 2021-02-11 | Kenny John P. (Chief Executive Officer) | Option Ex | 1,164 | 10.10 | 11,756 |
| 2021-02-08 | Baldasare Bryan T (Exec VP & CFO) | Sale | 6,254 | 30.00 | 187,620 |
| 2021-02-08 | Baldasare Bryan T (Exec VP & CFO) | Option Ex | 3,750 | 19.56 | 73,350 |
| 2021-02-08 | Kenny John P. (Chief Executive Officer) | Sale | 68,288 | 29.86 | 2,039,147 |
| 2021-02-08 | Kenny John P. (Chief Executive Officer) | Option Ex | 66,134 | 12.30 | 813,448 |
| 2021-02-08 | Rice John Mccune Jr. (Director) | Sale | 16,480 | 28.16 | 464,010 |
| 2021-02-08 | Rice John Mccune Jr. (Director) | Option Ex | 27,205 | 12.01 | 326,596 |
| 2021-02-05 | Baldasare Bryan T (Exec VP & CFO) | Sale | 14,250 | 26.61 | 379,121 |
| 2021-02-05 | Baldasare Bryan T (Exec VP & CFO) | Option Ex | 11,250 | 19.56 | 220,050 |
| 2021-02-05 | Kenny John P. (Chief Executive Officer) | Sale | 40,000 | 25.00 | 1,000,000 |
| 2020-11-25 | Bihl Anthony P Iii (Director) | Buy | 5,000 | 17.65 | 88,265 |
| 2020-06-30 | Baldasare Bryan T (Exec VP & CFO) | Option Ex | 1,500 | 19.71 | 29,565 |
| 2020-03-16 | Williams Felicia (Director) | Buy | 1,550 | 6.02 | 9,331 |
| 2020-03-12 | Kenny John P. (Chief Executive Officer) | Buy | 30,000 | 5.79 | 173,550 |
| 2020-03-10 | Baldasare Bryan T (Exec VP & CFO) | Buy | 2,000 | 6.97 | 13,936 |
| 2020-02-25 | Mcilwraith John (Director) | Buy | 5,000 | 7.59 | 37,950 |
| 2020-02-24 | Rice John Mccune Jr. (Director) | Buy | 3,000 | 7.52 | 22,548 |
| 2020-02-21 | Kenny John P. (Chief Executive Officer) | Buy | 10,000 | 7.66 | 76,550 |
| 2019-11-12 | Phillips David (Director) | Buy | 10,000 | 8.06 | 80,630 |
| 2019-11-08 | Kenny John P. (Chief Executive Officer) | Buy | 20,000 | 7.73 | 154,580 |
| 2019-05-22 | Rice John Mccune Jr. (Director) | Buy | 2,000 | 11.26 | 22,516 |
| 2019-05-16 | Anderson James M. (Director) | Buy | 5,000 | 11.37 | 56,855 |
| 2019-05-13 | Phillips David (Director) | Buy | 5,000 | 11.40 | 57,015 |
| 2019-05-08 | Kenny John P. (Chief Executive Officer) | Buy | 20,000 | 11.49 | 229,740 |
| 2018-11-28 | Ellingwood Dwight E (Director) | Buy | 31 | 18.42 | 571 |
| 2018-11-20 | Rice John Mccune Jr. (Director) | Option Ex | 2,000 | 13.55 | 27,100 |
| 2018-11-13 | Baldini Lawrence (EVP, Global Operations) | Sale | 9,876 | 19.55 | 193,046 |
| 2018-11-12 | Baldini Lawrence (EVP, Global Operations) | Sale | 25,225 | 19.35 | 488,179 |
| 2018-11-05 | Mcilwraith John (Director) | Option Ex | 2,000 | 12.80 | 25,600 |
| 2018-10-04 | Ellingwood Dwight E (Director) | Option Ex | 1,000 | 12.80 | 12,800 |
| 2018-08-24 | Mcilwraith John (Director) | Buy | 2,000 | 15.62 | 31,250 |
| 2018-08-16 | Ellingwood Dwight E (Director) | Buy | 38 | 14.91 | 566 |
| 2018-05-15 | Ellingwood Dwight E (Director) | Buy | 40 | 13.88 | 555 |
| 2018-02-23 | Mcilwraith John (Director) | Buy | 1,000 | 14.03 | 14,034 |
| 2018-02-13 | Ellingwood Dwight E (Director) | Buy | 39 | 14.13 | 551 |
| 2018-02-07 | Rice John Mccune Jr. (Director) | Buy | 1,000 | 14.75 | 14,750 |
| 2017-11-28 | Ellingwood Dwight E (Director) | Buy | 38 | 14.56 | 553 |
| 2017-08-24 | Kraeutler John A (Chairman and CEO) | Buy | 7,000 | 13.67 | 95,697 |
| 2017-08-14 | Ellingwood Dwight E (Director) | Buy | 39 | 13.94 | 543 |
| 2017-05-15 | Ellingwood Dwight E (Director) | Buy | 36 | 14.90 | 536 |
| 2017-02-13 | Ellingwood Dwight E (Director) | Buy | 41 | 12.93 | 530 |
| 2017-02-02 | Lueke Melissa (Exec VP, CFO) | Buy | 4,000 | 12.59 | 50,356 |
| 2017-01-26 | Baldini Lawrence (EVP, Pres Global Operations) | Buy | 4,000 | 12.70 | 50,800 |
| 2016-11-30 | Ellingwood Dwight E (Director) | Buy | 1,020 | 17.12 | 17,465 |
| 2016-11-28 | Ellingwood Dwight E (Director) | Buy | 38 | 17.07 | 648 |
| 2016-11-16 | Eberly Richard (EVP; Pres, Chief Comm Officer) | Sale | 4,926 | 17.00 | 83,756 |
| 2016-11-11 | Rolih Susan (EVP, Reg & Quality Systems) | Option Ex | 15,750 | 16.55 | 260,725 |
| 2016-11-04 | Kraeutler John A (Chairman and CEO) | Buy | 5,000 | 16.13 | 80,665 |
| 2016-11-03 | Baldini Lawrence (EVP, Pres Global Operations) | Buy | 4,900 | 16.00 | 78,400 |
| 2016-08-15 | Ellingwood Dwight E (Director) | Buy | 32 | 19.50 | 624 |
| 2016-08-11 | Mcilwraith John (Director) | Buy | 1,000 | 19.57 | 19,565 |
| 2016-07-22 | Phillips David (Director) | Option Ex | 7,500 | 18.07 | 135,555 |
| 2016-06-13 | Ellingwood Dwight E (Director) | Option Ex | 3,000 | 17.34 | 52,020 |
| 2016-05-16 | Ellingwood Dwight E (Director) | Buy | 33 | 19.06 | 628 |
| 2016-04-29 | Sazdanoff Catherine (Director) | Buy | 7,700 | 19.20 | 147,847 |
| 2016-02-12 | Ellingwood Dwight E (Director) | Buy | 32 | 19.62 | 627 |
| 2016-01-07 | Phillips David (Director) | Option Ex | 5,214 | 15.73 | 82,000 |
| 2015-12-09 | Elagin Vecheslav A (EVP, Research & Development) | Sale | 7,500 | 19.75 | 148,125 |
| 2015-12-01 | Eberly Richard (EVP,Pres Meridian Life Science) | Sale | 4,934 | 19.61 | 96,740 |
| 2015-11-23 | Ellingwood Dwight E (Director) | Buy | 32 | 19.27 | 616 |
| 2015-11-06 | Mcilwraith John (Director) | Buy | 1,000 | 20.19 | 20,187 |
| 2015-11-06 | Kraeutler John A (Chairman and CEO) | Option Ex | 15,750 | 14.01 | 220,610 |
| 2015-11-05 | Rolih Susan (EVP, Reg & Quality Systems) | Option Ex | 15,750 | 14.01 | 220,610 |
| 2015-11-05 | Lueke Melissa (Exec VP, CFO) | Option Ex | 15,750 | 14.01 | 220,610 |
| 2015-08-10 | Ellingwood Dwight E (Director) | Buy | 32 | 18.69 | 598 |
| 2015-05-11 | Ellingwood Dwight E (Director) | Buy | 32 | 18.52 | 592 |
| 2015-03-02 | Johnson Marviette D. (VP, Human Resources) | Sale | 1,917 | 19.91 | 38,169 |
| 2015-02-10 | Ellingwood Dwight E (Director) | Buy | 33 | 18.20 | 600 |
| 2015-01-23 | Ellingwood Dwight E (Director) | Buy | 1,980 | 17.74 | 35,125 |
| 2015-01-09 | Ready Robert J (Director) | Option Ex | 5,214 | 7.04 | 36,732 |
| 2014-12-01 | Rolih Susan (EVP, Reg & Quality Systems) | Sale | 11,219 | 16.46 | 184,664 |
| 2014-12-01 | Rolih Susan (EVP, Reg & Quality Systems) | Option Ex | 15,750 | 7.28 | 114,660 |
| 2014-11-24 | Eberly Richard (EVP,Pres Meridian Life Science) | Sale | 4,539 | 16.07 | 72,964 |
| 2014-11-21 | Ellingwood Dwight E (Director) | Buy | 1,000 | 16.08 | 16,082 |
| 2014-11-18 | Lueke Melissa (Exec VP, CFO) | Sale | 6,713 | 16.20 | 108,750 |
| 2014-11-18 | Lueke Melissa (Exec VP, CFO) | Option Ex | 10,500 | 7.28 | 76,440 |
| 2014-11-18 | Kraeutler John A (Chairman and CEO) | Sale | 10,500 | 16.20 | 170,110 |
| 2014-11-18 | Kraeutler John A (Chairman and CEO) | Option Ex | 10,500 | 7.28 | 76,440 |
| 2014-11-11 | Phillips David (Director) | Buy | 10,000 | 16.89 | 168,920 |
| 2014-06-13 | Ready Robert J (Director) | Sale | 2,700 | 20.04 | 54,094 |
Insider trading activities including stock purchases, stock sales, and option exercises of VIVO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Meridian Bioscience Inc (symbol VIVO, CIK number 794172) see the Securities and Exchange Commission (SEC) website.